Keyword

CSL112

Description: An investigational infused formulation of human apolipoprotein A-I studied for its effects on cholesterol transport and cardiovascular disease.
OpenAlex ID: keywords/csl112
2024 · C. Michael Gibson, Danielle Duffy, et al. · New England Journal of Medicine · 151
2013 · Svetlana Diditchenko, Andreas Gille, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 138
2014 · Andreas Gille, Rachael Easton, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 125
2013 · Rachael Easton, Andreas Gille, et al. · The Journal of Clinical Pharmacology · 98
2018 · Andreas Gille, Denise D’Andrea, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 72
2022 · Arzu Kalayci, C. Michael Gibson, et al. · Current Atherosclerosis Reports · 38
2022 · Bronwyn A. Kingwell, Stephen J. Nicholls, et al. · Journal of the American Heart Association · 34
2024 · Thomas J. Povsic, Serge Korjian, et al. · Journal of the American College of Cardiology · 33
2021 · Hongliang He, Kristen Hong, et al. · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · 29
2025 · Humam Emad Rajha, Ahmed Hassanein, et al. · International Journal of Molecular Sciences · 22
2023 · Luis Ortega-Paz, Salvatore Giordano, et al. · Clinical Pharmacokinetics · 18
2020 · Alexei V. Navdaev, Lorenzo Sborgi, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 18
2023 · Svetlana A. Didichenko, Elena Velkoska, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 15
2018 · Michael A. Tortorici, Danielle Duffy, et al. · Clinical Pharmacology in Drug Development · 14
Works count: 96
Citation count: 1,710
Year
Topic
Type